not tagged
not tagged
['mpnsm', '#mpn']
congress | #eha2022 | , reported outcomes in pts with tp53 mutation undergoing allo-hsct.
significant differences in tp53 vs non-tp53 groups, respectively:
- median os: 2.1 vs 15.4 yrs
- 6-year rfs: 35% vs 53% - survival after relapse: 92% vs 63% #mpnsm 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm